Join Yiannis Kiachopoulos, CEO of Causaly, as he deep dives into Generative AI (GenAI) and the challenges and opportunities it currently presents for Life Science research.
Discover how R&D organizations can evolve from AI conceptualization to transformative impact, focusing on strategies for large-scale adoption within existing scientific workflows for seamless integration and operational excellence.
What we'll cover:
AI in Pharma 2024
Explore the role of Large Language Models (LLMs) in pharmaceutical research and the transformative potential of GenAI in enabling knowledge-based organizations.
Challenges in Scaling AI Initiatives
Learn how to navigate the complexities of scaling AI solutions and discover strategies to transition from experimentation to full-scale implementation.
Blueprint for AI Success: Technology, Process, Partnerships
Set your team up for success, discover how to drive AI innovations in R&D through technology, process, and strategic partnerships.
.png?width=1200&height=236&name=Causaly%20logo%20(Medium).png "CausalyBlackLogo")
